Radio and PodcastLive Radio & PodcastsEpisode 3, Better Informed Patient Journeys
In the third episode of A Deep Dive Into HRD Testing in Ovarian Cancer, a three-part podcast series sponsored by AstraZeneca, we're speaking with Dr. David O'Malley, and Bobbie R, an ovarian cancer patient. Dr. O'Malley...
About This Episode
Episode 3, Better Informed Patient Journeys is an episode from Oncology Times - OT Broadcasts from the iPad Archives by Oncology Times. In the third episode of A Deep Dive Into HRD Testing in Ovarian Cancer, a three-part podcast series spon...
This episode belongs to Oncology Times - OT Broadcasts from the iPad Archives.
Use the player on this page to stream the episode online.
Published Feb 26, 2025, 12:27 long, audio available.
Questions About This Episode
What is Episode 3, Better Informed Patient Journeys about?
In the third episode of A Deep Dive Into HRD Testing in Ovarian Cancer, a three-part podcast series sponsored by AstraZeneca, we're speaking with Dr. David O'Malley, and Bobbie R, an ovarian cancer patient. Dr. O'Malley will highlight how HRD testing empowers ovarian cancer patients to make more informed decisions with their doctors to help guide their treatment journey, and Bobbie will provide insight into her experience with HRD testing. Dr. David O'Malley is a professor in the department of Obstetrics and Gynecology at The Ohio State University College of Medicine and the director of the Division of Gynecologic Oncology at the OSUCCC – James. Bobbie is a stage 3C ovarian cancer patient who lives in Rochester, New York. Bobbie is an animal rights activist, vegetarian, and exerciser who recently retired from the healthcare field, having worked as a registered nurse and owner of a healthcare staffing firm. Following her diagnosis in July of 2021, Bobbie participated in biomarker testing which indicated that she was breast cancer gene (BRCA) negative and homologous recombination deficiency (HRD) positive. After undergoing surgery and chemotherapy as first-line treatment, Bobbie's oncologist explained that she was eligible for a poly-ADP ribose polymerase (PARP) inhibitor due to her HRD status and on March 7, 2022, Bobbie started on a PARP inhibitor for maintenance treatment. As she continues treatment in 2024, Bobbie celebrates over 45 years of marriage with her husband and looks forward to traveling the United States, reading good books, and spending time with her dogs. For more information, visit For patient resources, please visit TestForHRD.com. This podcast does not necessarily reflect the opinions of AstraZeneca and are the spokespeople's opinions and experiences.
Where can I listen to Episode 3, Better Informed Patient Journeys?
You can listen to Episode 3, Better Informed Patient Journeys online on Radio and Podcast. Open the player on this page to stream the available audio.
Which podcast is Episode 3, Better Informed Patient Journeys from?
Episode 3, Better Informed Patient Journeys is an episode from Oncology Times - OT Broadcasts from the iPad Archives by Oncology Times.
How long is this episode?
This episode is 12:27 long.
When was this episode published?
This episode was published on Feb 26, 2025.
Can I save Episode 3, Better Informed Patient Journeys for later?
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Are there related episodes from Oncology Times - OT Broadcasts from the iPad Archives?
Yes. This page shows related episodes from Oncology Times - OT Broadcasts from the iPad Archives when more episodes are available from the podcast feed.
Quick Answers About This Episode
Where can I listen to Episode 3, Better Informed Patient Journeys?
You can listen to Episode 3, Better Informed Patient Journeys on this page when the episode audio is available from the podcast feed.
Which podcast is this episode from?
Episode 3, Better Informed Patient Journeys is from Oncology Times - OT Broadcasts from the iPad Archives by Oncology Times.
What are the episode details?
Published Feb 26, 2025 and 12:27 long